CLINICAL_TRIALS
trial_result
· 2023-10-17
Clinical Trial Update: Open-label Study of Dupilumab in Patients With Atopic Dermatitis [Phase 3]
Summary
Open-label Phase 3 trial investigating dupilumab in patients with atopic dermatitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2023-10-17